Literature DB >> 9272106

One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation.

G Dickstein1, D Spigel, E Arad, C Shechner.   

Abstract

There are many suggestions in the literature that the adrenal gland is more sensitive to ACTH in the evening than in the morning. However, all these studies in humans were conducted when the basal cortisol level was not suppressed, and were based on the observation that, after stimulation, the increases in cortisol differed, though the peak values were the same. To examine this, we established the lowest ACTH dose that caused a maximal cortisol stimulation even when the basal cortisol was suppressed, and used a smaller dose of ACTH for morning and evening stimulation. The lowest ACTH dose to achieve maximal stimulation was found to be 1.0 microgram, with which dose cortisol concentration increased to 607.2 +/- 182 nmol/l, compared with 612.7 +/- 140.8 nmol/l with the 250 micrograms test (P > 0.3). The use of smaller doses of ACTH (0.8 and 0.6 microgram) achieved significantly lower cortisol responses (312 +/- 179.4 and 323 +/- 157.3 nmol/l respectively; both P < 0.01 compared with the 1 microgram test). When a submaximal ACTH dose (0.6 microgram) was used to stimulate the adrenal at 0800 and 1600 h, after pretreatment with dexamethasone, no difference in response was noted at either 15 min (372.6 +/- 116 compared with 394.7 +/- 129.7 nmol/l) or 30 min (397.4 +/- 176.6 compared with 403 +/- 226.3 nmol/l; P > 0.3 for both times). These results show that 1.0 microgram ACTH, used latterly as a low-dose test, is very potent in stimulating the adrenal, even when baseline cortisol is suppressed; smaller doses cause reduction of this potency. Our data show that there is probably no diurnal variation in the response of the adrenal to ACTH, if one eliminates the influence of the basal cortisol level and uses physiologic rather than superphysiologic stimuli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272106     DOI: 10.1530/eje.0.1370172

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Adrenocortical and pituitary glucocorticoid feedback in abstinent alcohol-dependent women.

Authors:  Bryon Adinoff; Susan E Best; Wen Ye; Mark J Williams; Ali Iranmenesh
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

2.  Low dose (1 microg) adrenocorticotropin stimulation test in the evaluation of hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis.

Authors:  F Keleştimur; Z Göktaş; I Gülmez; K Unlühizarci; F Bayram; M Ozesmi; M Güven; A Tutuş
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

3.  Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.

Authors:  Robert L Rosenfield; Monica Mortensen; Kristen Wroblewski; Elizabeth Littlejohn; David A Ehrmann
Journal:  Hum Reprod       Date:  2011-09-09       Impact factor: 6.918

4.  Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease.

Authors:  G Aimaretti; C Baffoni; L Di Vito; S Grottoli; D Gaia; V Gasco; R Giordano; Z Zadik; F Camanni; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

5.  Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.

Authors:  M Calis; C Gökçe; F Ates; S Ulker; H B Izgi; H Demir; M Kirnap; S Sofuoglu; A C Durak; A Tutus; F Kelestimur
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 6.  Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

Authors:  Niki Rensen; Reinoud Jbj Gemke; Elvira C van Dalen; Joost Rotteveel; Gertjan Jl Kaspers
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

7.  Effect of very low LDL-cholesterol on cortisol synthesis.

Authors:  K Sezer; R Emral; D Corapcioglu; R Gen; E Akbay
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

8.  Adrenocortical function in Nigerians with human immunodeficiency virus infection.

Authors:  I A Odeniyi; O A Fasanmade; M O Ajala; A E Ohwovoriole
Journal:  Ghana Med J       Date:  2013-12

Review 9.  Mineralocorticoid responsive hyponatremia of the elderly: A systematic review.

Authors:  Kohta Katayama; Yasuharu Tokuda
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

10.  Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test.

Authors:  René Rodríguez-Gutiérrez; Adrian Rendon; Maximiliano Barrera-Sánchez; Kevin Erick Gabriel Carlos-Reyna; Neri Alejandro Álvarez-Villalobos; Gloria González-Saldivar; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2016-02-23       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.